Title : Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.

Pub. Date : 2010 Jul

PMID : 20487050






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In this group, treatment with ezetimibe/simvastatin 10/40 mg achieved target LDL-C levels in a significantly higher proportion of patients during a 6-week period than switching to either atorvastatin 40 mg or rosuvastatin 5-10 mg. Ezetimibe component of oligomeric golgi complex 2 Homo sapiens